We are a precision oncology company supported by world-class expertise in miRNA, machine learning, and keen to advance patient care
First, a small molecule called miRNA is extracted from the blood
The purified miRNA gets sequenced by a reading machine
The miRNA profile data is input into our Artificial Intelligence algorithm
The output risk score is presented to help determine the presence of cancer with oversight from a medical practitioner
miRNA has great potential biomarkers for evaluating cancer because of the ability to have signatures associated with tumors as the tissue of origin, progression, prognosis, and response to treatment
Machine learning is a subset of artificial intelligence (AI) that can learn from the data provided and improve from experience without being explicitly programmed
Machine learning makes it possible to extract hidden patterns from the whole miRNA expression profile in a multi-modal manner and classify the presence of different types of cancer.
Due to the nature of biology, some measurement and quantification errors still occur. Yet, PFM manages this problem with the combination of machine learning and bioinformatics.
Sign up to be the first to hear any updates